Revolution Medicines Correlations

RVMD Stock

USD 39.07 0.96 2.52%

The current 90-days correlation between Revolution Medicines and Blueprint Medicines Corp is 0.44 (i.e., Very weak diversification). The correlation of Revolution Medicines is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Revolution Medicines Correlation With Market

Very weak diversification

The correlation between Revolution Medicines and DJI is 0.41 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Revolution Medicines and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revolution Medicines. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade Revolution Stock refer to our How to Trade Revolution Stock guide.

Moving together with Revolution Stock

0.82	CDIOW	Cardio Diagnostics	Pair Corr
0.84	ELVN	Enliven Therapeutics	Pair Corr
0.66	SCLX	Scilex Holding	Pair Corr
0.77	ASMB	Assembly Biosciences Earnings Call This Week	Pair Corr
0.75	CDIO	Cardio Diagnostics	Pair Corr
0.83	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.66	DIS	Walt Disney	Pair Corr
0.71	MSFT	Microsoft	Pair Corr

Moving against Revolution Stock

0.63	LUCD	Lucid Diagnostics	Pair Corr
0.61	WM	Waste Management	Pair Corr
0.55	GE	GE Aerospace	Pair Corr
0.44	PLX	Protalix Biotherapeutics	Pair Corr
0.74	JNJ	Johnson Johnson	Pair Corr
0.74	CVX	Chevron Corp Sell-off Trend	Pair Corr
0.66	T	ATT Inc Earnings Call Today	Pair Corr
0.64	MMM	3M Company	Pair Corr
0.62	XOM	Exxon Mobil Corp Aggressive Push	Pair Corr
0.43	CSCO	Cisco Systems	Pair Corr
0.41	INTC	Intel	Pair Corr
0.39	IBM	International Business	Pair Corr

Related Correlations Analysis

	BPMC	SANA	KYMR	GLUE	TCRR	BDTX	BCEL	PASG	AKRO	RNA
BPMC		0.61	0.47	-0.3	0.0	0.69	0.0	0.15	0.18	0.23	BPMC
SANA	0.61		0.04	-0.6	0.0	0.2	0.0	-0.27	0.27	-0.04	SANA
KYMR	0.47	0.04		0.26	0.0	0.7	0.0	0.76	-0.56	0.05	KYMR
GLUE	-0.3	-0.6	0.26		0.0	0.22	0.0	0.37	-0.06	0.53	GLUE
TCRR	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	TCRR
BDTX	0.69	0.2	0.7	0.22	0.0		0.0	0.6	0.0	0.37	BDTX
BCEL	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	BCEL
PASG	0.15	-0.27	0.76	0.37	0.0	0.6	0.0		-0.55	0.02	PASG
AKRO	0.18	0.27	-0.56	-0.06	0.0	0.0	0.0	-0.55		0.54	AKRO
RNA	0.23	-0.04	0.05	0.53	0.0	0.37	0.0	0.02	0.54		RNA
	BPMC	SANA	KYMR	GLUE	TCRR	BDTX	BCEL	PASG	AKRO	RNA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

PASG	+ 0.76	KYMR
BDTX	+ 0.7	KYMR
BDTX	+ 0.69	BPMC
SANA	+ 0.61	BPMC
PASG	+ 0.6	BDTX
RNA	+ 0.54	AKRO

High negative correlations

GLUE	- 0.6	SANA
AKRO	- 0.56	KYMR
AKRO	- 0.55	PASG
GLUE	- 0.3	BPMC
PASG	- 0.27	SANA
AKRO	- 0.06	GLUE

Risk-Adjusted Indicators

There is a big difference between Revolution Stock performing well and Revolution Medicines Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Revolution Medicines' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
BPMC	2.13	0.05	0.00	(0.03)	0.00	0.00	5.39	(4.23)	26.30
SANA	7.56	1.66	0.22	0.58	6.10	(10.29)	10.15	(11.52)	178.30
KYMR	2.84	(0.23)	0.00	(0.23)	0.00	0.00	5.50	(7.08)	23.03
GLUE	3.56	(0.22)	0.00	(0.26)	0.00	0.00	7.34	(7.69)	19.92
TCRR	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
BDTX	3.94	(0.29)	0.00	(0.21)	0.00	0.00	7.09	(7.35)	29.04
BCEL	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PASG	4.19	(0.30)	0.00	(0.29)	0.00	0.00	7.69	(8.96)	56.48
AKRO	4.30	1.28	0.36	0.70	2.89	(5.76)	4.92	(5.64)	104.81
RNA	2.83	0.07	0.00	(0.02)	0.00	0.00	6.64	(4.79)	20.15

Revolution Medicines Corporate Management

David Pompliano	Founding Officer	Profile
Jack Anders	Chief Officer	Profile
Erin Graves	Senior Relations	Profile
Walter Reiher	Chief Officer	Profile
Path FRCP	Pres RD	Profile
Margaret JD	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC